0001209191-20-063657.txt : 20201215
0001209191-20-063657.hdr.sgml : 20201215
20201215205157
ACCESSION NUMBER: 0001209191-20-063657
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201214
FILED AS OF DATE: 20201215
DATE AS OF CHANGE: 20201215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHULZE GAIL
CENTRAL INDEX KEY: 0001023259
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21937
FILM NUMBER: 201391079
MAIL ADDRESS:
STREET 1: 3451 WELLS ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER NAME:
FORMER CONFORMED NAME: GAUMER SCHULZE GAIL
DATE OF NAME CHANGE: 20071030
FORMER NAME:
FORMER CONFORMED NAME: GAUMER GAIL
DATE OF NAME CHANGE: 19960919
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CERUS CORP
CENTRAL INDEX KEY: 0001020214
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 680262011
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1220 CONCORD AVENUE
STREET 2: SUITE 600
CITY: CONCORD
STATE: CA
ZIP: 94520
BUSINESS PHONE: 9252886000
MAIL ADDRESS:
STREET 1: 1220 CONCORD AVENUE
STREET 2: SUITE 600
CITY: CONCORD
STATE: CA
ZIP: 94520
FORMER COMPANY:
FORMER CONFORMED NAME: CERUS TECHNOLOGIES INC
DATE OF NAME CHANGE: 19960731
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-14
0
0001020214
CERUS CORP
CERS
0001023259
SCHULZE GAIL
C/O CERUS CORPORATION
1220 CONCORD AVE
CONCORD
CA
94520
1
0
0
0
Common Stock
2020-12-14
4
M
0
15000
2.48
A
62393
D
Common Stock
2020-12-14
4
S
0
15000
7.4752
D
47393
D
Common Stock
2020-12-14
4
S
0
47393
7.273
D
0
D
Option (Right to Buy)
2.48
2020-12-14
4
M
0
15000
D
2021-01-02
Common Stock
15000
0
D
The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.28 to $7.595 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.25 to $7.325 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
The option became exercisable in 12 equal monthly installments after the grant date.
Not applicable.
Gail Schulze by Chrystal Menard, attorney-in-fact
2020-12-15